defects, in which a similar phenomenon may reflect the existence of LOF and GOF alleles, 2 with residual presence of oligoclonal T (and occasionally, B) cells, and combined immunodeficiency associated with granulomas and/ or autoimmunity (CID-G/AI). 3 Overall, recognition of this broad spectrum of clinical and immunological phenotypes underpins the critical role of the RAG complex in immune homeostasis. Here, we will discuss recent advances in the mechanisms underlying the pathophysiology of the immune dysregulation associated with hypomorphic RAG mutations in patients and in animal models.
| MOLECUL AR AND B I O CHEMI C AL S TRUC TURE OF H UMAN R AG1 AND R AG2
The generation of an extensive repertoire of immunoglobulin an intervening D segment has to be joined to J before a V segment can be joined to the rearranged DJ product (the so-called "beyond 12/23 restriction"). 6, 7 The human RAG1 and RAG2 genes are located in a tail to tail configuration on chromosome 11p13 and are separated by only 8 kb. 8 Both the genomic organization of the RAG genes and the amino acid composition of the RAG proteins are highly conserved throughout evolution. Furthermore, the observation that RAG proteins share similarities with various transposases and can mediate transposition 9, 10 supports the hypothesis that the RAG recombinase originates from a common transposable element that entered the genome of a common ancestor of all jawed vertebrate. Consistent with this hypothesis, the ProtoRAG transposon superfamily has been recently identified in the genome of the basal chordate Amphioxus [11] [12] [13] .
Multiple levels of regulation of RAG gene expression have been hypothesized to occur because of the on-off fluctuation observed during lymphocyte development. Furthermore, expression of the RAG proteins is also regulated at the post-translational level. In vitro and in vivo data indicate the existence of cis-regulatory elements in the RAG locus, and an additional regulatory mechanism has been described to mediate the regulated degradation of the RAG2 protein via phosphorylation at threonine 490 (T490) and targeting to the ubiquitin-proteosomal pathway. formation of a circular DNA product containing the signal ends. 14, 15 During the joining process, asymmetrical opening of the hairpin by ARTEMIS may allow incorporation of palindromic sequences (Pnucleotides), and terminal deoxynucleotidyl transferase (TdT) may introduce additional nucleotides (N-nucleotides) in the coding sequence.
| S TRUC TURE OF THE H UMAN R AG 1 AND R AG2 PROTEIN S
The RAG1 and RAG2 protein sequences are not related to each other. The human RAG1 protein is composed of 1043 amino acids.
The N-terminal region of the protein has been implicated in nonspecific interactions and involved in ubiquitylation-dependent regulatory processes. 7 It contains a series of basic motifs, involved in RAG1 subnuclear localization, a C3HC4 RING finger domain followed by a zinc finger motif that coordinates zinc ions and has histone H3 ubiquitin ligase activity. Nuclear magnetic resonance and crystallography studies have suggested that these motifs are located in functionally relevant structural domains, 16, 17 and this hypothesis has been confirmed by in vitro analysis of recombination activity of mutant RAG proteins. 18 The The RAG2 protein is composed of 527 amino acids. The RAG2
biochemically competent "core" is included in the region spanning amino acids 1-383 or 1-387, 7 although recent evidence indicates amino acids 1-351 as the minimal RAG2 region required for catalytic function of the RAG complex. 23 Secondary structure prediction and mutagenesis studies have suggested that the core domain of RAG2 adopts a six-bladed beta-propeller fold structure with the second beta-strand of each repeat highly conserved both within and between kelch repeat-containing proteins. 24, 25 This core region is essential for DNA cleavage activity and enhances RSS binding and interaction with RAG1. Extensive site-directed mutagenesis studies within each of the six kelch motifs revealed the critical role of both hydrophobic and glycine-rich regions within the second beta-strand for RAG1-RAG2 interaction and recombination signal recognition and cleavage. 24 Furthermore, residues 350-383
are responsible for demethylation of the endogenous Igκ locus in pre-B cells through a RAG1-independent process. 26 The C terminus "noncore" region (amino acids 384-527) contains multiple regulatory motifs and is involved both in chromatin accessibility and in the inhibitory regulation of RAG2 expression. A highly conserved acidic "hinge" region plays a critical role in post-cleavage DNA ends stabilization and DNA repair pathway choice. 27 Importantly, a noncanonical plant homeodomain (PHD) (amino acids 414-487)
is involved in chromatin interaction by binding to histone 3 carrying a trimethylated lysine 4 (H3K4me3), an epigenetic marker of active transcription start sites. 25, 28, 29 Binding of the PHD to H3K4me3 promotes recombination activity of the RAG complex.
Phosphorylation of residue T490 by the cyclin A-CDK2 complex controls the proper expression of the RAG2 before G1 to S phase transition in the cell cycle. 30 The phosphorylated RAG2 protein is polyubiquitylated by the (S-phase kinase-associated protein (SKP2)-SKp1-CUL1-F box) SCF complex and targeted for proteasomal degradation. 31 The critical role of this motif has been further confirmed by the generation of mouse models carrying deletion in the RAG2 C-terminal domain. Destabilization of the postcleavage RAG complex and increased aberrant recombination product including chromosomal translocations involving VDJ loci were observed in mutants lacking the C-terminal residues 352-527. 27, [32] [33] [34] Furthermore, p53-deficient animals carrying a core RAG2 deletion have increased NHEJ activity associated with genomic instability and accelerated lymphomagenesis. 34, 35 The crystal and cryo-electron microscopy structures of RAG1/ 
| S PEC TRUM OF CLINI C AL MANIFE S TATI ON S C AUS ED BY R AG G E N E DEFEC TS
Defects in RAG genes cause a large spectrum of clinical phenotypes in humans. 3 Following the demonstration that disruption of Rag1 [54] [55] [56] [57] [58] [59] Therefore, we proposed that this phenotype be defined as "combined immunodeficiency with granuloma and/or autoimmunity" (CID-G/AI). 60 In a series of 68 patients with CID-G/AI included in a recent review, we observed that autoimmune cytopenias were particularly common, being found in 53% of the patients. 3 However, severe vasculitis and organ-specific autoimmunity affecting gut, liver, thyroid, kidney, and muscles. Recurrent respiratory tract infections leading to bronchiectasis, and chronic and recurrent viral infections due to herpesviruses and human papillomavirus have been frequently reported in patients with CID-G/AI. Fatal progressive multifocal leukoencephalopathy caused by to JC virus infection has been seen in one patient. 59 Interestingly, the presence of the rubella virus vaccine strain has been demonstrated in the granulomas of some of these patients. 61 The immunological phenotype of RAG deficiency manifesting as CID-G/AI is variable. T cells are usually present in lower number, and the proportion of naïve T cells is also reduced; however, in vitro T-cell proliferation to mitogens is often normal or modestly reduced. Circulating B cells are present in variable number; immunoglobulin serum levels are often normal but may also be low or high, and specific antibody responses may be variably affected. 3 Finally, these patients produce a broad spectrum of autoantibodies; neutralizing anti-cytokine antibodies directed against interferon-α and IFN-ω has been reported, especially in patients with a history of varicella zoster virus infection. 60, 62 Moreover, patients with hypomorphic RAG mutations may initially be given other diagnoses, including idiopathic CD4 + lymphopenia, 63 common variable immunodeficiency, 64, 65 IgA deficiency, 66 selective deficiency of polysaccharide-specific antibodies, 67 hyperIgM syndrome, 68 and autoimmune lymphoproliferative syndrome. 69 Although at least in some of these cases, the clinical and laboratory data were clearly suggestive of a combined immunodeficiency, the fact remains that these clinical examples have taught us how diverse is the clinical and immunological phenotype associated with hypomorphic RAG mutations. we have further modified the flow cytometry-based assay by using bicistronic vectors that allow simultaneous expression of two RAG variants at 1:1 ratio. 73 As the RAG complex is a heterotetramer, use of bicistronic vectors is especially important to assess the net effect of compound heterozygous missense mutations.
| G ENOT YPE-PHENOT YPE CORREL ATI ON IN R AG DEFI CIEN C Y
Overall, these assays have demonstrated that naturally occurring missense RAG mutations present a wide range of recombination activity, with robust, albeit not absolute correlation with the clinical and immunological phenotype. 3 They have also helped demonstrate that some variants that had been reported in patients with SCID/ OS, support wildtype levels of recombination activity, and therefore are presumably not disease causing, as shown for the RAG2 N474S variant. 73, 74 Another evidence in favor of genotype-phenotype correlation in RAG deficiency comes from studies of the diversity of T-and Bcell repertoire based on high-throughput sequencing of rearrange- T reg cells, but rather activated T cells, as also indicated by defective suppression function. 76, 92 Finally, analysis of amino acid usage at positions P6-P7 of the TCRβ CDR3 region of sorted T conv cells revealed increase usage of amino acids associated with self-reactivity, 93 suggesting that RAG deficiency may also affect negative selection.
| MOUS E MODEL S OF N ULL AND HYP OMORPHIC R AG M UTATI O N S
Generation of mouse models has been instrumental to unveil the in vivo effects of RAG mutations (Table 1) . Functional disruption of either Rag1 or Rag2 genes by homologous recombination leads to a lymphoid arrest at a stage prior to the recombination of the antigen receptor loci, corresponding to double negative 3 (DN3) and pre-B cells along T-and B-cell development, respectively. 38, 39, 94 Accordingly, these mice show the absence of peripheral T and B lymphocytes.
To define the specific role played by the different domains of the RAG proteins, additional mouse models have been generated. In particular, a Rag2 mutant lacking the C-terminal domain of the protein and carrying only the core region of Rag2 (and for this reason named "core-RAG2 knock-in" mouse) showed a partial block in lymphocyte development, with severe impairment of V(D)J recombination at the Igh and Trb loci, that affected proximal and distal V gene segments equivalently. 95, 96 However, these models do not recapitulate the broad spectrum of clinical phenotypes seen in patients, and in particular the immune dysregulation that is often associated with hypomorphic RAG muta- At the same time when we described Rag2 R229Q/R229Q mice, the Marrack laboratory reported a spontaneous mouse mutant (named mutant mouse, MM), carrying a homozygous point mutation (R972Q) in the Rag1 gene. 99 Compound heterozygosity for the equivalent mutation (R975Q) in human RAG1, in association with the R396L mutation, had been previously reported by our group in another patient with OS. 50 This mutant mouse was also described as a model of OS. However, although it had several features of OS (low number of T and B cells, presence of an oligoclonal T-cell repertoire, predominance of peripheral activated/memory T cells that responded poorly to mitogens, and peripheral eosinophilia), it lacked the prominent T-cell infiltrates in the skin and other tissues that characterize the human disease. 99 Furthermore, MM mice showed high levels of IgM, IgG, and IgE and were able to mount normal antibody responses to T-dependent and independent antigens. Intriguingly, germinal centers were detected in high number in MM mice in the absence of immunization.
In parallel, Rag1 S723C/S723C mice were generated by JoAnn Sekiguchi 100 and further characterized by our group. 101, 102 In this particular case, the decision to generate this mutant was not dictated by attempting to model in mice the effects of a naturally occurring human mutation, but rather to test in vivo the consequences of a mutation that results in a production of RAG1 protein that is proficient for DNA cleavage, but defective in postcleavage complex formation and end joining in vitro. Rag1 S723C/S723C mice showed an incomplete block in T-cell development, with accumulation of DN3 cells in the thymus, and a more severe block in B-cell development at the pro-B stage, with few pre-B cells and the absence of immature and mature B cells in the bone marrow. 100 In spite of this, Rag1 S723C/ S723C mice were shown to produce high amounts of low-affinity selfreactive antibodies, associated with accumulation of plasma cells in extrafollicular areas. 101 While the Rag mutant mice reported above may represent valuable models of OS and AS, none of them recapitulates the human CID-G/AI phenotype. In order to generate such a model, we used CRISPR-based gene editing to introduce in the coding flank-sensitive region of RAG1 CTD mutations that are equivalent to those identified in patients with CID-G/AI. In particular, we generated three mouse models, homozygous for F971L, R972Q and R972W amino acid changes. 91 One of these models (the Rag1 R972Q mouse) carries the same mutation as the MM mouse model reported above. Based on structural modeling, this mutation and the F971L mutation were predicted to be less severe than the R972W mutation. These different mutants represent a suitable platform to test the hypothesis that mutations in the coding flank-sensitive region of RAG1 alter selection of V, D, and J genes targeted to recombination, perturbing T-and B-cell repertoire prior to positive selection. Overall, mouse models carrying hypomorphic Rag mutations represent a useful tool to address some of mechanisms of immune dysregulation left unsolved in human pathology. within the medulla, also contribute to self-antigen presentation, while migratory cDCs, scattered between the medulla and the cortex, have the dual function to transport peripheral acquired self-antigens and to process blood-borne self-antigens. 106 More recently, another transcription factor, Fezf2, has also been proposed to regulate expression of a large number of TRAs. 104, 107 Interaction between TECs and thymic DCs has been implicated to mediate differentiation of self-reactive thymocytes into natural T reg (nT reg ) cells. Collectively, these findings demonstrate that in conditions asso- 
Both T-and B-cell development were severely compromised in
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